Open Congress : Comments on H.Con.Res.342 Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Open Congress : Comments on H.Con.Res.342 Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. 2008-05-13T15:43:11Z opencongress.org tag:opencongress.org,2007:/bill/comments/50533 New comment by Jadziapax 2008-05-13T15:43:11Z tag:opencongress.org,2008-05-13:/comment/14511 Jadziapax I have been taking estriol for nearly 4 years and my sister for more than 5 years. We both have multiple sclerosis and estriol was shown in a small study, to decrease the number of new lesions and improve the cognitive function in those patients with MS. Now their is a new clinical study beginning to test estriol alongside the MS drug copaxone. My sister can no longer get her estriol and is not eligible for the new clinical trial. I have applied for the clinical trial, but I am unsure if I will be accepted. I think it's criminal to disregard the health of MS patients who are currently taking estriol, the safest of ALL the estrogens, for the sake of big Pharma. Please pass this bill!!